Australian Government announces “patent box” scheme to boost medical and biotech innovation
Written By
Partner
Australia
I am a partner in our Intellectual Property Group, based in Sydney. My experience spans the breadth and depth of IP issues, but my specialty is complex IP litigation and disputes including contentious patent, trade mark, copyright, and confidential information and consumer protection/passing-off matters.
Associate
UK
I am an Associate in our Intellectual Property Group in London, with a particular focus on the life sciences, pharmaceutical and chemical sectors.
Related
Practices
Sectors
Regions
Countries
The Australian Government has committed $206.4 million to a patent box tax incentive scheme to encourage investment in medical and biotechnology innovation.
Patent box schemes are a type of tax incentive where income from certain types of patents is taxed a preferential lower corporate tax rate. Australia will join over 20 other countries including the UK, France, China, Belgium and Switzerland in offering patent box type tax incentive schemes.
The scheme will come into effect from 1 July 2022 and will apply to granted patents that were filed after 11 May 2021. Although the details of the scheme are yet to be finalised, income derived solely from eligible…
Full article available on PatentHub
Latest insights
More Insights
Pantech v Google: Tokyo District Court grants first injunction for SEP infringement
3 minutes Sep 08 2025
EU Revised Product Liability Directive 2024: Navigating the New Liability Framework for Non-EU Manufacturers
6 minutes Sep 04 2025
UPC Litigation Risks for Chinese Firms: Service Delays Could Mean Surprise Judgments
3 minutes Sep 01 2025